Vibrating tendons may steady shaky legs — a trial puts it to the test
NCT ID NCT07726043
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether adding focal tendon vibration to a two-week intensive rehabilitation program can improve balance in adults with Charcot-Marie-Tooth disease type 1A (CMT1A). CMT1A causes progressive muscle weakness and poor balance, often leading to falls. Participants will undergo a multidisciplinary rehab program with or without vibration applied to the quadriceps tendon. The main goal is to see if the vibration-enhanced program leads to better scores on the Berg Balance Scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a 2-week intensive multidisciplinary rehabilitation program combined with focal tendon vibratory stimulation
- What this could lead to
- If it works, this could point toward a standardized, non-drug therapy to improve balance and reduce falls in people with CMT1A.
- What could go wrong
- This is a small, early-stage trial with only 30 participants. The vibration technique is still experimental for CMT, and benefits may not be large or long-lasting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE TYPE 1A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUR Valmante Sud
RECRUITINGMarseille, 13009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.